ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 349447 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 349447; 2) Community: the network communities that were significantly associated with the response to NSC 349447; 3) Molecule: the relationships between components within communities and NSC 349447; 4) MDR: the compounds that were significantly associated with the NSC 349447.

NSC Compound Enrichment Correlation
NSC 702137 Null 0.0133986477026052 -0.22783168
NSC 702323 Null 0.0133986477026052 0.067131019
NSC 709362 Acetamide, N,N'-(1,5-pentanediyl)bis[2-(1,3,5,11a-tetrahydro- 5-oxopyrrolo[2,1-c][1,4]benzodiazepin-2-ylidene)- 0.0133986477026052 0.18122428
NSC 709437 Null 0.0133986477026052 0.19516797
NSC 718729 Cyclopent-4-ene-1,3-dione, 2-[[4-hydroxy-3,5-bis(1,1-dimethylethyl)phenyl]methyl]- 0.0133986477026052 0.081180588
NSC 719376 Null 0.0133986477026052 0.27583624
NSC 719690 11-Cyanomethylen-11H-indolo[1,2-a]indazole 0.0133986477026052 -0.1993762
NSC 720426 Null 0.0133986477026052 -0.1399584
NSC 726770 Cis-6-(2-dimethylamino-1-ethyl)-5,6,12,13-tetrahydro-2,3-dim ethoxy-8,9-(methylenedioxy)-5,11-dioxo-11H-indeno-[1,2-c]iso quinoline 0.0133986477026052 0.35615589
NSC 727082 16-[3-Methoxy-4-(2-piperidin-1-yl ethoxy)benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.0133986477026052 0.24424411
Total:152  Current:62    [First] [Prev] [Next] [Last]